Open for Research: CCIL’s TEP Shared Resource Offers Variety of Lab Services

The Tumor Engineering and Phenotyping (TEP) Shared Resource, a laboratory located at the University of Illinois, is now providing a variety of research services.

The Biosafety Level 2 (BSL2) laboratory offers researchers a dedicated space to access specialized technologies, resources, and expertise. BSL2 labs follow strict safety protocols and have specialized equipment to allow personnel to handle pathogenic material. Trained TEP staff are available to start assisting on projects and performing experiments. Current equipment includes:

  • BioTek Cytation 5
  • Seahorse XFE 96 Analyzer
  • NanoString nCounter
  • CHEF Mapper XA Pulsed Field Electrophoresis System

In addition to the robust technology available, TEP has established a central cell bank system. This system currently has an estimated 200 cell lines available for campus researchers, and TEP provides customized 2D and 3D cell culture services. Researchers can also submit mycoplasma samples to be tested by PCR and electrophoresis. TEP’s mycoplasma testing allows sensitive and specific detection of several different species of mycoplasma.

“The Cancer Center at Illinois collaborated closely with scientists at the Beckman Institute to receive the NIH grant responsible for this incredible campus resource,” said Rohit Bhargava, CCIL Director. “The Tumor Engineering and Phenotyping Shared Resource will enhance the revolutionary work conducted by Cancer Center at Illinois members and progress ground-breaking discoveries.”

As TEP continues its renovation in the lower level of the Beckman Institute, TEP’s permanent residence, the services and equipment provided will increase. The TEP Shared Resource is available year-round for campus use. CCIL members will receive priority access.

To schedule use of TEP’s resources, contact Hui Xu, TEP Research Coordinator.